Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
UTHR:BMV
United Therapeutics Corp
MXN 9 643,95
0,00%
(0,00) 1D
12 Mrt., 10:53:11 GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for UTHR...
Mkt. cap
24,67 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
MXN 9 643,95
52-wk low
MXN 5 672,39
No. of employees
1 k
News stories
From sources across the web
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1,4 k
Founded1996
HeadquartersSilver Spring, Maryland, Verenigde State van Amerika
Sector-
Websiteunither.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
794,40 m
798,60 m
799,50 m
790,20 m
Cost of goods sold
92,50 m
87,60 m
100,90 m
103,40 m
Cost of revenue
92,50 m
87,60 m
100,90 m
103,40 m
Research and development expenses
149,00 m
134,00 m
127,50 m
139,50 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
170,10 m
190,80 m
181,80 m
189,90 m
Operating expense
319,10 m
324,80 m
309,30 m
329,40 m
Total operating expenses
411,60 m
412,40 m
410,20 m
432,80 m
Operating income
382,80 m
386,20 m
389,30 m
357,40 m
Other non operating income
1,00 m
3,90 m
300,00 k
800,00 k
EBT including unusual items
423,50 m
408,40 m
438,00 m
444,00 m
EBT excluding unusual items
428,80 m
434,10 m
433,00 m
398,30 m
Income tax expense
101,30 m
98,90 m
99,30 m
79,70 m
Effective tax rate
23,92%
24,22%
22,67%
17,95%
Other operating expenses
-
-
-
-
Net income
322,20 m
309,50 m
338,70 m
364,30 m
Net profit margin
40,56%
38,76%
42,36%
46,10%
Earnings per share
6,63
6,41
7,16
7,70
Interest and investment income
51,10 m
51,30 m
46,40 m
43,20 m
Interest expense
-6,10 m
-7,30 m
-3,00 m
-3,10 m
Net interest expenses
45,00 m
44,00 m
43,40 m
40,10 m
Depreciation and amortization charges
-
-
-
-
EBITDA
402,60 m
407,30 m
411,20 m
380,20 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer